Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection-Reference-Cited by-同舟云学术

Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection

Published:1999-12 Issue:6 Volume:117 Page:1386-1396
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Maini Mala K.,Boni Carolina,Ogg Graham S.,King Abigail S.,Reignat Stephanie,Lee Chun Kyon,Larrubia Juan R.,Webster George J.M.,McMichael Andrew J.,Ferrari Carlo,Williams Roger,Vergani Diego,Bertoletti Antonio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Hepatitis B virus immunopathogenesis;Chisari;Annu Rev Immunol,1995

2. Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carr ying substitutions within the epitope;Bertoletti;J Exp Med,1994

3. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice;Moriyama;Science,1990

4. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen;Penna;J Exp Med,1991

5. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection;Nayersina;J Immunol,1993

Cited by 318 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection;JHEP Reports;2024-02

2. Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers;Journal of Hepatology;2024-01

3. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy;Antiviral Research;2024-01

4. IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B;Hepatology Communications;2023-12

5. Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’;Journal of Hepatology;2023-11